Rishi Gupta - Insider Trading & Ownership

Location
C/O Chemocentryx, Inc., 850 Maude Avenue, Mountain View, CA
Summary
The estimated net worth of Rishi Gupta is at least $177M dollars as of August 8, 2025. Rishi Gupta is the Director, 10%+ Owner of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $170M. Rishi Gupta is the Director of Verona Pharma plc and owns shares of Verona Pharma plc (VRNA) stock worth about $7.46M.
Signature
/s/ Rishi Gupta
All Insider Reports
All Insider Reports

Ownership of Rishi Gupta

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. Director, 10%+ Owner $170M Feb 6, 2025
VRNA Verona Pharma plc Director $7.46M May 11, 2023
TSBX Turnstone Biologics Corp. Director $0 Aug 8, 2025

Insider Transactions Reported by Rishi Gupta:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.